The latest news

Mar 30, 2023

CLIA-Certified Personalized Blood Test for Multiple Myeloma, Wearable Sensor Detects Blood Biomarker for Heart Attacks, More

Mar 20, 2023

Fierce Medtech's 2022 Fierce 15

Mar 17, 2023

Biden's 'Cancer Moonshot' is already being fueled by tech addressing breast cancer

Mar 8, 2023

PreciseDx to Present on AI-enabled Breast Cancer Grade and Phenotyping Assay at United States and Canadian Academy of Pathology (USCAP) Annual Meeting

Mar 8, 2023

PreciseDx to Present on AI-enabled Breast Cancer Grade and Phenotyping Assay at United States and Canadian Academy of Pathology (USCAP) Annual Meeting

Feb 24, 2023

Subsidiary of VC-Backed ElevateBio Draws Moderna’s Attention

Feb 22, 2023

Bradley Gendell named chief financial officer for PreciseDx

Feb 22, 2023

HemaChrome Wins the NIH’s RADx Tech for Maternal Health Challenge, Next-Generation Pathology Analysis Enriches Breast Cancer Grading, More

Feb 22, 2023

PreciseDx Appoints Bradley Gendell as Chief Financial Officer

Feb 21, 2023

PreciseDx: Bradley Gendell